Symbol
EGRX
Investment type
Equity / Common stock, $0.001 par value per share
Latest Disclosed Ownership
811K shares
Security Ownership
6.24%

NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP ownership in Eagle Pharmaceuticals, Inc. Common stock, $0.001 par value per share (EGRX)

2025-02-19 - NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 811K shares of Eagle Pharmaceuticals, Inc. Common stock, $0.001 par value per share (EGRX). This represents 6.24% percent ownership of the company.